Brought to you by 
Scynexis assists Plexxikon in chemistry efforts
22 Nov 2022
Executive Summary
Start-up company Plexxikon (structural genomics) will use Scynexis Chemistry & Automation's (synthesis chemistry) MedChem-Factory automation and high-throughput technology to accelerate its own chemistry programs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Technologies
- Molecular Diversity
-
Drug Discovery Technologies
Deal Status
- Final
Deal Type
-
Alliance
- R&D (No Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Scynexis assists Plexxikon in chemistry efforts
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice